Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to -$253.9 million.

  • BIO-TECHNE's Cash from Financing Activities fell 282.02% to -$44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.5 million, marking a year-over-year decrease of 39.45%. This contributed to the annual value of -$253.9 million for FY2025, which is 107.44% down from last year.
  • Latest data reveals that BIO-TECHNE reported Cash from Financing Activities of -$253.9 million as of FY2025, which was down 107.44% from -$122.4 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Cash from Financing Activities registered a high of $22.6 million during FY2023, and its lowest value of -$253.9 million during FY2025.
  • In the last 3 years, BIO-TECHNE's Cash from Financing Activities had a median value of -$122.4 million in 2024 and averaged -$117.9 million.
  • As far as peak fluctuations go, BIO-TECHNE's Cash from Financing Activities spiked by 109.31% in 2023, and later tumbled by 641.20% in 2024.
  • BIO-TECHNE's Cash from Financing Activities (Yearly) stood at -$62.6 million in 2021, then plummeted by 288.25% to -$242.9 million in 2022, then spiked by 109.31% to $22.6 million in 2023, then crashed by 641.20% to -$122.4 million in 2024, then crashed by 107.44% to -$253.9 million in 2025.